Indications |
Intravenous Hypovolaemic shock Adult: As dextran 40: Initially, 10 ml/kg given by rapid infusion as a 10% solution in sodium chloride 0.9% or glucose 5%. Doses may be given daily for up to 5 days. As dextran 70: Initially, 500-1000 mL of a 6% solution in sodium chloride 0.9% or glucose 5% infused at a rate of 20-40 mL/min. Maintenance: 10 ml/kg/day for3 days (Dextran 70). Max Dosage: Intravenous Thromboembolic disorders Adult: As dextran 40: Initially, 500 ml of a 10% solution in sodium chloride 0.9% or glucose 5% infused over 4-6 hr, followed by 500 ml infused over 4-6 hr on the next and subsequent alternate days for not more than 10 days. Child: As dextran 40: Up to 5 ml/kg in infants and 10 ml/kg in children. Intravenous Prophylaxis of postoperative thromboembolic disorders Adult: As dextran 40: 500 ml of a 10% solution in sodium chloride 0.9% or glucose 5% infused over 4-6 hr during or at the end of the surgery. Dose may be repeated the following day and treatment may be continued on alternate days for up to 10 days in high-risk patient. Child: As dextran 40: Up to 10 ml/kg in children. Intravenous Prophylaxis of pulmonary embolism or venous thrombosis in moderate- to high-risk patients undergoing surgery Adult: As dextran 70: Initially, 500-1000 mL of a 6% solution in sodium chloride 0.9% or glucose 5% infused over 4-6 hr during or immediately after surgery, followed by 500 mL on the next day and on subsequent alternate days for up to 2 wk after surgery in high-risk patients. Intrauterine As an aid in hysteroscopy Adult: As dextran 70: 50-100 mL of a 32% solution instilled into the uterus as a rinsing and dilatation fluid. |
Contraindications |
Hypersensitivity. Severe renal disease with oliguria or anuria. Marked cardiac decompensation. Pregnancy. |
Warnings / Precautions |
Lactation. |
Adverse Reactions |
GI disturbances; headache, dizziness; allergic reactions; raised liver enzyme values; alopecia; bone marrow suppression. |
Drug Interactions |
Enzyme inducers e.g. phenytoin or carbamazepine and enzyme inhibitors e.g. cimetidine. See Below for More dextran Drug Interactions |
Mechanism of Actions |
Dextrans produce expansion of plasma volume. It also reduces blood viscosity and inhibits sludging or aggregation of red blood cells. Metabolism: Dextrans with molecular weight>50,000 are slowly metabolised to glucose. Excretion: Urine: 50% (as unchanged dextran 70 within 24 hr); 70% (as unchanged dextran 40 within 24 hr). Dextrans with molecular weight<50,000 are excreted unchanged by the kidney; small amounts are eliminated in the faeces. |
Storage Conditions |
Intrauterine: Store at 25°C. Intravenous: Store at 25°C. |
ATC Classification |
B05AA05 - dextran ; Belongs to the class of blood substitutes and plasma protein fractions. Used as blood substitutes. |
Storage |
Intrauterine: Store at 25°C. Intravenous: Store at 25°C. |
Available As |
|
Dextran
Post Review about Dextran Click here to cancel reply.
Dextran Containing Brands
Dextran is used in following diseases
Drug - Drug Interactions of Dextran
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.